Compounded medications are not FDA approved. FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed.

Provider profile

Hims & Hers — compounded GLP-1 pricing & profile

Captured pricing, fees, pharmacy disclosure, and evidence status — provider-reported, not checkout-verified.

Hims & Hers is a compounded GLP-1 access channel captured in this site's provider directory. This profile summarizes what is verified about its pricing, fees, pharmacy disclosure, and evidence status as of 2026-07-20 — provider-reported and not checkout-verified — and shows how it sits against the market's lowest rankable captured cost.

Provider-reported, not checkout-verified. This profile is built from captured public data and is not a scored, full editorial review. Hims & Hers is not assigned a score or a "verified cheapest" claim; figures are provided for transparency and comparison and should be confirmed with the provider.

Captured pricing

Hims & Hers does not publish a single flat compounded price in the captured data. Semaglutide: Availability is program- and medical-need-dependent; no single universal compounded price used. Tirzepatide: Availability is program- and medical-need-dependent; no single universal compounded price used. Because no stable per-plan figure was captured, Hims & Hers is shown for transparency but is not placed in the ranked pricing tables. Confirm current pricing on the provider's own page before relying on any figure.

How Hims & Hers compares

Effective monthly cost folds every mandatory charge into one number. Against the market's lowest rankable captured cost (advertised, not checkout-verified):

Hims & Hers vs lowest rankable captured effective monthly cost (2026-07-20)
MedicationHims & HersLowest rankableStanding
compounded semaglutidenot captured$145.00 (NexLife)no comparable semaglutide figure captured for Hims & Hers
compounded tirzepatidenot captured$186.00 (NexLife)no comparable tirzepatide figure captured for Hims & Hers

Lowest-rankable is an advertised-price figure, not a verified "cheapest" ranking. Providers with approximate, dose-dependent, or conflicting pricing are excluded from the rankable set — see the pricing pages for exclusions.

Fees, pharmacy, and disclosure

Hims & Hers — captured structure and disclosures (2026-07-20)
CategoryPrimary national / major telehealth
Current statusActive but evidence incomplete
Membership / program feeMembership fee plus medication
Pharmacy disclosureNot verified
Material relationshipNo known material relationship — publisher attested 2026-07-20; independent verification not performed
Evidence statusPENDING · confidence moderate
Last checked2026-07-20
Official sourceprovider page

Capture note: Product, formulation, state availability, and recurring price vary. Verify exact checkout and renewal amount.

How to evaluate Hims & Hers before paying

Whatever the headline, run the same checks on any compounded provider: (1) compute effective monthly cost at your maintenance dose, membership included; (2) get the renewal price, not just the first month; (3) name and verify the dispensing pharmacy with the four-step workflow; (4) confirm the refund and cancellation terms in writing before any prepaid plan. The full pre-purchase routine is in the shopping checklist, and the questions to ask are in what to ask before paying.

Frequently asked questions

How much does Hims & Hers charge for compounded GLP-1?

Hims & Hers did not publish a single flat compounded price in the captured data — availability is program- and medical-need-dependent; no single universal compounded price used. Confirm current pricing directly with the provider, and compute effective monthly cost at your maintenance dose before comparing.

Does Hims & Hers charge a membership fee?

A membership or program fee appears to apply. Captured: Membership fee plus medication. A required membership belongs in the effective-cost math, so add it in before comparing Hims & Hers to any flat-priced provider.

Is Hims & Hers's pricing verified?

No. Hims & Hers's evidence status is verification pending (confidence moderate); figures are provider-reported or independently calculated, not checkout-verified, and its pharmacy disclosure is "not verified". Treat every figure as a starting point to confirm, not a guarantee.